1 - 10 of 52 articles
DRUG RESISTANCE keeps cancer chemotherapy from working the way it should. Because chemotherapy employs drugs that kill tumor cells preferentially, it should eradicate the malignancy before irreversible damage is done to the host. But it fails to do so when, at concentrations that are tolerable...
WHEN GENE THERAPY becomes clinical reality, one of its first uses may be in treating cancer patients with drug-resistant tumors.
John S. Lazo, PhD, associate professor of pharmacology, Yale University School of Medicine, New Haven, Conn, told the Bristol Myers Symposium on Cancer Research that...
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract CONVENTIONAL CANCER THERAPY can still be effective after tumors have become drug-resistant, according to some oncologists. They say that the secret is to...
ONCOGENES are no longer the only genes associated with carcinogenesis. The first anti-oncogene has been identified. It is linked to the development of the childhood cancer retinoblastoma, and investigators think that anti-oncogenes may play a role in other cancers as well.
Read and print from thousands of top scholarly journals.
Continue with Facebook
Sign up with Google
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.